Algorithm aims to spot rare heart disease in medical records
NCT ID NCT04569903
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study aimed to test a computer algorithm that uses insurance claims data to identify people with ATTR amyloidosis, a rare disease that affects the heart and nerves. Researchers planned to check how well the algorithm worked by reviewing medical records. However, the study was withdrawn before any participants were enrolled.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Computer algorithm for ATTR
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRANSTHYRETIN AMYLOIDOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Yale New Haven Hospital
New Haven, Connecticut, 06520, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heart drug acoramidis tested for Long-Term cardiac repair in rare amyloidosis
- New study tracks safety of eplontersen in patients with liver transplants
- Carpal tunnel surgery could spot hidden heart disease risk
- AI spots heart clues in bone scans: a new way to catch a silent killer?
- Can MRI and nerve tests catch a rare disease before symptoms start?
- New italian registry aims to unlock secrets of rare heart disease